US Stock MarketDetailed Quotes

TELO Telomir Pharmaceuticals

Watchlist

5.510
+0.010+0.18%

Close Jun 12 16:00 ET

163.15MMarket Cap-8663P/E (TTM)

Telomir Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

296.75%1.92M

361.52%3.94M

121.44%1.08M

308.64%954.15K

1,935.76%1.43M

482.94K

518.36%854.15K

487.1K

233.5K

70.06K

Selling and administrative expenses

1,640.58%741.54K

2,766.11%600.19K

3,937.28%395.29K

2,625.09%102.19K

1,502.85%60.11K

--42.6K

79.92%20.94K

--9.79K

--3.75K

-General and administrative expense

1,640.58%741.54K

2,766.11%600.19K

3,937.28%395.29K

2,625.09%102.19K

1,502.85%60.11K

--42.6K

79.92%20.94K

--9.79K

--3.75K

Research and development costs

82.59%804.02K

88.95%1.57M

-57.31%203.78K

14.28%262.56K

906.76%667.63K

--440.34K

558.70%833.21K

--477.31K

--229.75K

--66.31K

Other operating expenses

--370.5K

--1.77M

--479.55K

--589.4K

--698.6K

----

Operating profit

-296.75%-1.92M

-361.52%-3.94M

-121.44%-1.08M

-308.64%-954.15K

-1,935.76%-1.43M

-482.94K

-518.36%-854.15K

-487.1K

-233.5K

-70.06K

Net non-operating interest income expense

-4.34M

-1.64M

-761.82K

-757.17K

-124.05K

Non-operating interest expense

--4.34M

--1.64M

--761.82K

--757.17K

--124.05K

--0

Other net income (expense)

-7.49M

Special income (charges)

----

---7.49M

----

--0

----

-Less:Other special charges

----

--7.49M

----

Income before tax

-1,195.12%-6.25M

-1,430.40%-13.07M

-1,814.86%-9.33M

-632.91%-1.71M

-2,112.81%-1.55M

-482.94K

-518.36%-854.15K

-487.1K

-233.5K

-70.06K

Income tax

Net income

-1,195.12%-6.25M

-1,430.40%-13.07M

-1,814.86%-9.33M

-632.91%-1.71M

-2,112.81%-1.55M

-482.94K

-518.36%-854.15K

-487.1K

-233.5K

-70.06K

Net income continuous Operations

-1,195.12%-6.25M

-1,430.40%-13.07M

-1,814.86%-9.33M

-632.91%-1.71M

-2,112.81%-1.55M

---482.94K

-518.36%-854.15K

---487.1K

---233.5K

---70.06K

Minority interest income

Net income attributable to the parent company

-1,195.12%-6.25M

-1,430.40%-13.07M

-1,814.86%-9.33M

-632.91%-1.71M

-2,112.81%-1.55M

-482.94K

-518.36%-854.15K

-487.1K

-233.5K

-70.06K

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-1,195.12%-6.25M

-1,430.40%-13.07M

-1,814.86%-9.33M

-632.91%-1.71M

-2,112.81%-1.55M

-482.94K

-518.36%-854.15K

-487.1K

-233.5K

-70.06K

Basic earnings per share

-1,310.18%-0.23

-1,430.39%-0.4415

-1,814.92%-0.315

-632.89%-0.0578

-2,113.06%-0.0524

-0.0163

-518.37%-0.0288

-0.0165

-0.0079

-0.0024

Diluted earnings per share

-1,310.18%-0.23

-1,430.39%-0.4415

-1,814.92%-0.315

-632.89%-0.0578

-2,113.06%-0.0524

-0.0163

-518.37%-0.0288

-0.0165

-0.0079

-0.0024

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	296.75%1.92M	361.52%3.94M	121.44%1.08M	308.64%954.15K	1,935.76%1.43M	482.94K	518.36%854.15K	487.1K	233.5K	70.06K
Selling and administrative expenses	1,640.58%741.54K	2,766.11%600.19K	3,937.28%395.29K	2,625.09%102.19K	1,502.85%60.11K	--42.6K	79.92%20.94K	--9.79K	--3.75K	--3.75K
-General and administrative expense	1,640.58%741.54K	2,766.11%600.19K	3,937.28%395.29K	2,625.09%102.19K	1,502.85%60.11K	--42.6K	79.92%20.94K	--9.79K	--3.75K	--3.75K
Research and development costs	82.59%804.02K	88.95%1.57M	-57.31%203.78K	14.28%262.56K	906.76%667.63K	--440.34K	558.70%833.21K	--477.31K	--229.75K	--66.31K
Other operating expenses	--370.5K	--1.77M	--479.55K	--589.4K	--698.6K	----	----	----	----	----
Operating profit	-296.75%-1.92M	-361.52%-3.94M	-121.44%-1.08M	-308.64%-954.15K	-1,935.76%-1.43M	-482.94K	-518.36%-854.15K	-487.1K	-233.5K	-70.06K
Net non-operating interest income expense	-4.34M	-1.64M	-761.82K	-757.17K	-124.05K	0	0	0	0	0
Non-operating interest expense	--4.34M	--1.64M	--761.82K	--757.17K	--124.05K	--0	--0	--0	--0	--0
Other net income (expense)		-7.49M
Special income (charges)	----	---7.49M	----	----	----	----	--0	----	----	----
-Less:Other special charges	----	--7.49M	----	----	----	----	----	----	----	----
Income before tax	-1,195.12%-6.25M	-1,430.40%-13.07M	-1,814.86%-9.33M	-632.91%-1.71M	-2,112.81%-1.55M	-482.94K	-518.36%-854.15K	-487.1K	-233.5K	-70.06K
Income tax
Net income	-1,195.12%-6.25M	-1,430.40%-13.07M	-1,814.86%-9.33M	-632.91%-1.71M	-2,112.81%-1.55M	-482.94K	-518.36%-854.15K	-487.1K	-233.5K	-70.06K
Net income continuous Operations	-1,195.12%-6.25M	-1,430.40%-13.07M	-1,814.86%-9.33M	-632.91%-1.71M	-2,112.81%-1.55M	---482.94K	-518.36%-854.15K	---487.1K	---233.5K	---70.06K
Minority interest income
Net income attributable to the parent company	-1,195.12%-6.25M	-1,430.40%-13.07M	-1,814.86%-9.33M	-632.91%-1.71M	-2,112.81%-1.55M	-482.94K	-518.36%-854.15K	-487.1K	-233.5K	-70.06K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-1,195.12%-6.25M	-1,430.40%-13.07M	-1,814.86%-9.33M	-632.91%-1.71M	-2,112.81%-1.55M	-482.94K	-518.36%-854.15K	-487.1K	-233.5K	-70.06K
Basic earnings per share	-1,310.18%-0.23	-1,430.39%-0.4415	-1,814.92%-0.315	-632.89%-0.0578	-2,113.06%-0.0524	-0.0163	-518.37%-0.0288	-0.0165	-0.0079	-0.0024
Diluted earnings per share	-1,310.18%-0.23	-1,430.39%-0.4415	-1,814.92%-0.315	-632.89%-0.0578	-2,113.06%-0.0524	-0.0163	-518.37%-0.0288	-0.0165	-0.0079	-0.0024
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Overall